Black Cancer Survivors Get Real Boost From Exercise
Regular exercise can benefit recovery of black cancer survivors, but most don’t get the recommended amount of activity, according to a recent study. The American...
Category : Cancer
Prevent Cancer
You can’t prevent cancer, can you? It’s a common belief that if cancer doesn’t run in your family, it’s unlikely you’ll receive a cancer diagnosis....
Rep. John Lewis Being Treated for Pancreatic Cancer
Rep. John Lewis announced Sunday he has been diagnosed with stage 4 pancreatic cancer. The 79-year-old said the diagnosis came during a “routine medical visit and...
Can You Have Sex During Chemo?
It’s best to discuss any concerns about chemotherapy and sex with your doctor, who’s familiar with your individual situation. In general, however, it’s usually OK...
Racial Gap in Cancer Deaths Continues to Narrow
Black women still more likely to die from breast cancer, black men from colon cancer The gap in cancer deaths in the United States has...
8 Chemo Hacks for Trainwrecked Tastebuds
As folks who have made it through chemotherapy and come out the other side can attest, some cancer treatments can change your body’s response to...
7 Unexpected Signs of Breast Cancer
Early detection of breast cancer leads to better survival rates. And while finding a lump in their breast is the most common way women diagnosed...
10 Alternative Cancer Treatments Worth Trying
Alternative cancer treatments can’t cure your cancer, but they may provide some relief from signs and symptoms. These 10 alternative cancer treatments have shown some...
Kemi Doll, M.D.: We Need to Change the Conversation About Endometrial Cancer
Endometrial cancer is the most common gynecological cancer in the United States. Most women, about 75 percent, will be diagnosed in the early stages of...
FDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma
Merck and Eisai today announced that the U.S. Food and Drug Administration (FDA) approved the combination of KEYTRUDA, Merck’s antiPD-1 therapy, plus LENVIMA, the orally...
